Article ID Journal Published Year Pages File Type
5699820 Clinical Oncology 2006 8 Pages PDF
Abstract
The present study indicates an independent benefit on biochemical outcome of high-dose 3DCRT for low-, intermediate- and high-risk patients and of long-term AAD in high-risk prostate cancer patients.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Dose Escalation with Three-dimensional Conformal Radiotherapy for Prostate Cancer. Is More Dose Really Better in High-risk Patients Treated with Androgen Deprivation?
Authors
, , , , ,